Business Orchestra BioMed says BACKBEAT trial on track, R110m cash gives runway into late 2027 Rajesh Pillay · August 11, 2026
Business Biohaven advances first extracellular degraders, phases in pivotal trials and Regeneron pact Rajesh Pillay · August 10, 2026
Business
